Genes in irritable bowel syndrome
Pan-European interdisciplinary network to identify genetic factors (human genetics, epigenetics, metagenomics) contributing to IBS etiopathogenesis
An action in the Biomedicine and Molecular Biosciences (BMBS) domain
within COST (European Cooperation in Science and Technology)
of the European Science Foundation
in the European Union
Press Releases / News
GENIEUR Newsletter No 1/2017
25 January 2017
Two markers related to the alteration of the epithelial permeability in irritable bowel syndrome patients discovered. Teams in Barcelona (Vicario and Santos et al.) and Heidelberg (Martinez and Niesler et al.) published their research based on the first joint venture initiated at the GENIEUR Starter Meeting in Bologna in 2012 in Gut.
Press release Barcelona
16 December 2016
GENIEUR Newsletter No 2/2016
5 July 2016
GENIEUR Newsletter No 1/2016
1 June 2016
ESNM Report: COST Action BM1106 GENIEUR Training School and Final Conference in Heidelberg
19 May 2016
GENIEUR state of the art reviews on the role of diet on microbiota composition in IBS (WG4) (Rajilic et al., 2015), on unravelling the genetic basis in IBS (Gazouli et al., 2016 and other key contributions from GENIEUR members to the IBS field were included in Nature outlook and an online collection on IBS in Nature.
17 May 2016
Position paper on phenotyping tool recommendations of WG1&2 in collaboration with GENIEUR members accepted for publication in Neurogastroenterology and Motility.
>> read more
Interdisciplinary team of colleagues involved in GENIEUR wraps up the status quo in IBS >> Article in Nature Reviews Disease Primers.
>> read more
GENIEUR Reloaded launched at the GENIEUR Final Conference: ESNM endorsed two more years and gives support.
>> read more
1 February 2016
GENIEUR International team received UEG LINK Award
'HELP IBS in Europe' for further implementation of the GENIEUR basic protocol in countries where no (genetic) IBS research is currently established.
>> read more
The GENIEUR Genetics and Epigenetics Working Group WG3 reports on the state of the art in Genetics and Epigenetics in IBS: status quo and future recommendations: our vision Article in Nature Reviews Gastroenterology and Hepatology.
>> read more
GENIEUR members involved in replication and meta-analysis of immunogenes.
>> read more
The GENIEUR Microbiota Working Group WG4 wrapped up the current knowledge on the role of diet on microbiota in IBS.
>> read more
GENIEUR members involved in replication of first population-based GWAS.
>> read more
GENIEUR members involved in position paper how to tackle epigenetics and genetics work in the future in Europe.
>> read more
Europe-wide network for investigating irritable bowel syndrome headed by Heidelberg University Hospital/European Science Foundation provides 500,000 euros in funding for understanding causes, improving options for diagnosis and treatment
>> read more